Horizon Therapeutics plc Named One of the Best Adoption-Friendly Workplaces by the Dave Thomas Foundation for Adoption
October 23 2020 - 8:00AM
Business Wire
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that is
has been named one of the top 100 adoption-friendly workplaces in
the United States by the Dave Thomas Foundation for Adoption,
ranking number 39 overall and number two in the pharmaceutical
category. The list recognizes organizations with the most robust
adoption benefit programs, comparing financial reimbursement and
paid leave offered to employees who adopt, based on a survey of
organizations across the country.
“I know personally the profound impact adoption can have on a
child’s life,” said Tim Walbert, chairman, president and chief
executive officer, Horizon. “At Horizon, providing comprehensive
adoption support is a priority – both for our employees through our
best-in-class benefits and the communities we serve through our
#RAREis Adoption Fund. Every child deserves a permanent and loving
home and we are proud to be leading the way.”
Horizon’s adoption assistance benefit provides up to $10,000
reimbursement for expenses related to the adoption of a child and
adoptive parents receive up to 10 weeks of paid time off to spend
with their new child. Additionally, Horizon oversees the #RAREis
Adoption Fund, which helps facilitate global adoptions of children
with rare diseases in partnership with Gift of Adoption. The
#RAREis Adoption Fund supports Gift of Adoption’s mission to
provide financial assistance to complete the final steps of
adoption of at-risk children. More than 35% of the financial grants
provided by Gift of Adoption support finalizing adoptions of
children with medical needs and close to half of these adoptions
are for children with rare diseases. Horizon’s three-year
commitment will support the adoption of more than 30 children
living with rare diseases.
About Horizon
Horizon is focused on researching, developing and
commercializing medicines that address critical needs for people
impacted by rare and rheumatic diseases. Our pipeline is
purposeful: we apply scientific expertise and courage to bring
clinically meaningful therapies to patients. We believe science and
compassion must work together to transform lives. For more
information on how we go to incredible lengths to impact lives,
please visit www.horizontherapeutics.com and follow us on Twitter,
LinkedIn, Instagram and Facebook.
About the Dave Thomas Foundation for Adoption
The Dave Thomas Foundation for Adoption is a national, nonprofit
public charity dedicated exclusively to finding permanent homes for
the more than 150,000 children waiting in North America’s foster
care systems. Created by Wendy’s founder Dave Thomas, who was
adopted, the Foundation implements evidence-based, results-driven
national service programs, foster care adoption awareness campaigns
and innovative grantmaking. To learn more, visit
davethomasfoundation.org.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201023005101/en/
U.S. Media Contact: Geoff Curtis Executive Vice
President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com
Ireland Media: Ray Gordon Gordon MRM ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Apr 2023 to Apr 2024